Literature DB >> 10364762

Congenital cystic mesoblastic nephroma.

S Campagnola1, L Fasoli, P Flessati, M Sulpasso, R Balter, M Pea, R Caudana.   

Abstract

Congenital mesoblastic nephroma is a relatively rare infantile renal tumor. It comprises 3-6% of renal masses in childhood and 50% during the neonatal period. Most mesoblastic nephroma occur in the newborn period, with 80% of the cases being reported within the first month of life. Macroscopically the tumor is composed of a solid mass of different sizes tending to invade the surrounding structures and renal parenchyma. The authors report a case of cystic mesoblastic nephroma of the cellular subtype, with diffuse areas of hemorrhage and necrosis. The tumor was treated by surgical excision with radical nephrectomy and the child is doing well 4 years after the operation.

Entities:  

Mesh:

Year:  1998        PMID: 10364762     DOI: 10.1159/000030342

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  5 in total

1.  Fetal biparametric MR imaging in the diagnosis of congenital mesoblastic nephroma.

Authors:  Lucia Manganaro; Bernardo Silvia; Amanda Antonelli; Valeria Rondoni; Teresa Pusiol; Michele Scialpi
Journal:  Turk J Urol       Date:  2018-05-01

Review 2.  Review of paraneoplastic syndromes in children.

Authors:  Grace My Ma; Jeanne S Chow; George A Taylor
Journal:  Pediatr Radiol       Date:  2019-03-16

3.  Atypical congenital mesoblastic nephroma presenting in the perinatal period.

Authors:  Vinci S Jones; Ralph C Cohen
Journal:  Pediatr Surg Int       Date:  2006-11-09       Impact factor: 1.827

4.  Congenital Giant Dysplastic Kidney Presenting as Respiratory Distress: A Case Report.

Authors:  Mahesh Kumar; Geeta Gathwala; K N Ratttan; Sandeep Lather; Poonam Dalal
Journal:  J Neonatal Surg       Date:  2017-01-01

5.  A case of fetal congenital mesoblastic nephroma with oligohydramnios.

Authors:  Cheol Hong Kim; Yoon Ha Kim; Moon Kyoung Cho; Ki Min Kim; Jin A Ha; Eun Hyun Joo; Seok Mo Kim; Tae-Bok Song
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.